MDT MD

MDT Medtronic plc.

Healthcare · Medical Devices

7 · Solide Momentum 6.0 · Neutral Sicher Aristokrat

92.39

-1.89%

Über das Unternehmen

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients in the United States, Ireland, and internationally. It operates through three segments: The Cardiovascular Portfolio, Neuroscience Portfolio, and Medical Surgical Portfolio. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves, left atrial appendage exclusion systems, extracorporeal membrane oxygenation (ECMO) systems and percutaneous coronary intervention products, percutaneous angioplasty balloons, and endovenous products. The Neuroscience Portfolio segment offers medical devices and implants, biologic solutions, spinal cord stimulation and brain modulation systems, implantable drug infusion systems, and interventional products, as well as nerve ablation system under the Accurian name. This segment offers its products for spinal surgeons, neurosurgeons, neurologists, pain management specialists, anesthesiologists, orthopedic surgeons, urologists, urogynecologists, and interventional radiologists, as well as ear, nose, and throat specialists, and energy surgical instruments. The Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure and electrosurgery products, AI-powered surgical video and analytics platform, robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology products, gastrointestinal and hepatologic diagnostics and therapies, and therapies to treat diseases and conditions, and patient monitoring and airway management products, as well as insulin pumps and consumables, continuous glucose monitoring systems, and sensors. Medtronic plc was founded in 1949 and is headquartered in Galway, Ireland.

3.12%
70.94%
2.88
118.2B
22.76
4.06
89.72

52-Wochen-Spanne

92.4
Tief 73.3 Hoch 106
Rendite Wachstum Momentum Sicherheit Wert Gesundheit

Dividenden-Tiefenanalyse

Medtronic plc. (MDT) operates in the Medical Devices industry within the Healthcare sector. The company currently offers a dividend yield of 3.12%. This yield is above its 5-year average of 2.96% and falls within its 5-year yield band of 2.09% to 3.35%. Medtronic is recognized as a Dividend Champion with 28 consecutive years of dividend increases. Valuation analysis indicates its price is considered fair by Yield Theory, although one fair value model suggests it is currently expensive, being 33.4% above a fair value of USD 61.55.

Dividendenhistorie

Medtronic plc. has demonstrated consistent dividend growth, maintaining a streak of 28 consecutive years of increases, earning it a Dividend Champion status. Over the past three years, the dividend has grown at a CAGR of 1.45%, while the five-year CAGR stands at 4.13%. Annual dividends per share have progressed from USD 1.22 in 2014 to USD 1.84 in 2017, USD 2.16 in 2019, USD 2.52 in 2021, and USD 2.80 in 2024. The projected dividend for 2025 is USD 2.84.

Dividendensicherheit

The dividend safety for Medtronic plc. shows a payout ratio of 70.94% based on earnings, indicating a significant portion of earnings is distributed as dividends. The company's financial health includes a debt-to-equity ratio of 55.365%.

Quantic · Kostenlos

Lies den Rest zur Dividendensicherheit

Dazu die wichtigsten Risiken und worauf als Nächstes zu achten ist. Kostenlos, ohne Karte.

KI-generiert aus den Dividendendaten von Quantic · Aktualisiert am 9 Sep 2026 · Nur zur Information – keine Finanzberatung.

Auf Englisch angezeigt — eine Übersetzung folgt in Kürze.

Kursverlauf

133 102 70.6 2021 2022 2023 2024 2025 2026 2020-10 · 101 2020-11 · 114 2020-12 · 117 2021-01 · 111 2021-02 · 117 2021-03 · 118 2021-04 · 131 2021-05 · 127 2021-06 · 124 2021-07 · 131 2021-08 · 133 2021-09 · 125 2021-10 · 120 2021-11 · 107 2021-12 · 103 2022-01 · 103 2022-02 · 105 2022-03 · 111 2022-04 · 104 2022-05 · 100 2022-06 · 89.8 2022-07 · 92.5 2022-08 · 87.9 2022-09 · 80.8 2022-10 · 87.3 2022-11 · 79.0 2022-12 · 77.7 2023-01 · 83.7 2023-02 · 82.8 2023-03 · 80.6 2023-04 · 91.0 2023-05 · 82.8 2023-06 · 88.1 2023-07 · 87.8 2023-08 · 81.5 2023-09 · 78.4 2023-10 · 70.6 2023-11 · 79.3 2023-12 · 82.4 2024-01 · 87.5 2024-02 · 83.4 2024-03 · 87.2 2024-04 · 80.2 2024-05 · 81.4 2024-06 · 78.7 2024-07 · 80.3 2024-08 · 88.6 2024-09 · 90.0 2024-10 · 89.3 2024-11 · 86.5 2024-12 · 79.9 2025-01 · 90.8 2025-02 · 92.0 2025-03 · 89.9 2025-04 · 84.8 2025-05 · 83.0 2025-06 · 87.2 2025-07 · 90.2 2025-08 · 92.8 2025-09 · 95.2 2025-10 · 90.7 2025-11 · 105 2025-12 · 96.1 2026-01 · 103 2026-02 · 97.7 2026-03 · 86.7 2026-04 · 81.0 2026-05 · 73.8 2026-06 · 78.2 2026-07 · 85.4 2026-08 · 90.7 2026-09 · 92.4
Kurs

Dividendenprofil

Frequenz
Vierteljährlich
Wachstum (TTM)
+1.4%
CAGR 3J
+1.4%
+4.1%
28 Jahre

(5 Jahre)

Jetzt 3.1%
2.1% Ø 3.0% 3.4%

Zahlungskalender

Jan
Feb
Mär
Apr
Mai
Jun
Jul
Aug
Sep
Okt
Nov
Dez

Dividendenhistorie

CAGR 3J +1.4% CAGR 5J +4.1% 28J.-Serie
14 15 16 17 18 19 20 21 22 23 24 25

Dividende je Aktie nach Jahr

Quantic · Kostenlos

Bewertung & Strategie freischalten

Zwei DDM-Fair-Values, Sicherheitsmarge, Bewertungsrang im Sektor, Dividendenrendite-Theorie, Verdopplungszeit und maximaler Drawdown.

Verschuldung & Hebel

55.4%
2.07
1.29
Schulden vs Barmittel
Schulden Barmittel
Gesamtverschuldung
28.2B USD
Liquide Mittel gesamt
8.8B USD
10.4B USD

Zuletzt gemeldete Bilanzkennzahlen.

Von 1 Anleger gehalten

Erscheint in diesen Listen

MDT erfüllt die Kriterien dieser Dividenden-Rankings.

Nur zur Information – keine Finanzberatung.

Quantic · Kostenlos

Verfolge MDT und dein ganzes Portfolio

Echte Rendite, Dividendensicherheit, Nettoeinkommen nach Steuern und dein Weg zur Freiheit — kostenlos, ohne Broker-Verbindung.

€0

Brauchst du mehr? Pro bringt mehr Portfolios, Optionseinkommen-Tracking und mehr KI. Pro ansehen →